Dysregulation of the TGF-β pathway has been implicated in many human diseases including neoplastic[8,11], fibrotic[2,9], and cardiovascular diseases[10], but TGF-β involvement in these pathological conditions is complex and sometimes paradoxical[11,12]. This evidence concerns the gene TGFB1 and cardiovascular disorder.